Compare Check Point Software Technologies Ltd (CHKP) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Check Point Software Technologies Ltd vs Recursion Pharmaceuticals Inc — how do they compare? Check Point Software Technologies Ltd trades at $127.43 (market cap $13.18B), while Recursion Pharmaceuticals Inc trades at $3.34 (market cap $1.81B). The key difference: Check Point Software Technologies Ltd is far larger — about 7.3× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| CHKP | RXRX | |
|---|---|---|
Market Cap | $13.18B | $1.81B |
Sector | Technology | Health |
52-Week High | $206.91 | $6.79 |
52-Week Low | $112.47 | $2.84 |
Enterprise Value | $12.88B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Check Point Software Technologies Ltd
Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.
Read more on CHKP →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
